$1.67 Billion is the total value of First Light Asset Management, LLC's 79 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 15.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPNE | Buy | SEASPINE HOLDINGS CORP | $122,824,000 | +30.1% | 5,988,509 | +10.4% | 7.37% | +17.7% |
| PRTA | Sell | PROTHENA CORPORATION PLC | $99,110,000 | +34.4% | 1,927,829 | -34.3% | 5.95% | +21.6% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $93,103,000 | +11.0% | 2,050,273 | +1.9% | 5.59% | +0.5% |
| CDNA | Sell | CAREDX INC | $82,025,000 | -0.7% | 896,257 | -26.1% | 4.92% | -10.1% |
| MODN | Buy | MODEL N INC | $74,090,000 | +7.9% | 2,161,936 | +10.9% | 4.44% | -2.4% |
| ATRC | Sell | ATRICURE INC | $61,304,000 | +13.0% | 772,775 | -6.7% | 3.68% | +2.3% |
| OMCL | Buy | OMNICELL INC | $57,724,000 | +17.3% | 381,145 | +0.5% | 3.46% | +6.1% |
| NEO | Buy | NEOGENOMICS INC | $51,898,000 | +7.3% | 1,148,945 | +14.5% | 3.11% | -2.9% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $51,486,000 | +11.1% | 528,606 | +0.7% | 3.09% | +0.5% |
| CUTR | Sell | CUTERA INC | $49,889,000 | +33.4% | 1,017,523 | -18.2% | 2.99% | +20.7% |
| AXGN | Sell | AXOGEN INC | $48,010,000 | -7.3% | 2,221,673 | -13.1% | 2.88% | -16.2% |
| HCAT | Sell | HEALTH CATALYST INC | $43,819,000 | -6.0% | 789,393 | -20.8% | 2.63% | -15.0% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $42,088,000 | +75.2% | 617,124 | +78.2% | 2.52% | +58.5% |
| OPRX | Buy | OPTIMIZERX CORP | $41,154,000 | +42.1% | 664,842 | +11.9% | 2.47% | +28.5% |
| INSM | Buy | INSMED INC | $39,436,000 | +21.8% | 1,385,648 | +45.7% | 2.37% | +10.1% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $39,332,000 | +26.2% | 3,471,459 | +32.3% | 2.36% | +14.2% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $38,559,000 | +8.3% | 465,572 | -13.3% | 2.31% | -2.0% |
| STRO | Buy | SUTRO BIOPHARMA INC | $38,535,000 | -17.7% | 2,072,875 | +0.7% | 2.31% | -25.6% |
| XENT | Buy | INTERSECT ENT INC | $37,785,000 | -11.1% | 2,210,970 | +8.6% | 2.27% | -19.6% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $35,812,000 | -5.4% | 526,650 | +7.1% | 2.15% | -14.5% |
| GKOS | Sell | GLAUKOS CORPORATION | $34,708,000 | -22.4% | 409,144 | -23.2% | 2.08% | -29.8% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $32,116,000 | +12.5% | 950,192 | +0.6% | 1.93% | +1.8% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $31,322,000 | +0.8% | 274,780 | +6.3% | 1.88% | -8.8% |
| TPTX | Buy | TURNING POINT THERAPEUTICS | $30,882,000 | +454.5% | 395,825 | +572.3% | 1.85% | +402.2% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $29,434,000 | -30.6% | 2,973,092 | -19.1% | 1.77% | -37.2% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $26,976,000 | +125.7% | 1,760,811 | +132.6% | 1.62% | +104.0% |
| KRMD | Sell | REPRO-MED SYSTEMS INC | $25,115,000 | +30.1% | 5,424,347 | -1.1% | 1.51% | +17.7% |
| GMAB | Sell | GENMAB AS | $24,786,000 | +2.4% | 607,046 | -17.7% | 1.49% | -7.4% |
| STIM | Buy | NEURONETICS INC | $23,451,000 | +64.9% | 1,463,836 | +27.3% | 1.41% | +49.2% |
| SIBN | Buy | SI-BONE INC | $22,162,000 | -0.7% | 704,230 | +0.4% | 1.33% | -10.1% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $21,859,000 | -11.7% | 229,246 | +5.4% | 1.31% | -20.2% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $21,107,000 | +25.2% | 332,873 | +18.2% | 1.27% | +13.2% |
| MEIP | Buy | MEI PHARMA INC | $19,938,000 | -8.9% | 6,995,707 | +9.7% | 1.20% | -17.6% |
| CDXS | Sell | CODEXIS INC | $15,934,000 | -1.1% | 703,166 | -0.1% | 0.96% | -10.6% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $14,524,000 | +31.0% | 229,876 | +1.1% | 0.87% | +18.5% |
| RLAY | New | RELAY THERAPEUTICS INC | $14,290,000 | – | 390,555 | +100.0% | 0.86% | – |
| ITMR | Buy | ITAMAR MEDICAL LTD | $13,810,000 | +53.8% | 586,420 | +56.4% | 0.83% | +39.3% |
| Buy | APTOSE BIOSCIENCES INC | $13,663,000 | -26.3% | 4,115,411 | +32.6% | 0.82% | -33.3% | |
| Buy | AKUMIN INC | $11,214,000 | +52.0% | 3,559,911 | +78.5% | 0.67% | +37.6% | |
| XBI | New | SPDR S&P BIOTECH ETF | $11,193,000 | – | 82,669 | +100.0% | 0.67% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $10,572,000 | -42.1% | 644,216 | -22.1% | 0.63% | -47.6% |
| JYNT | Sell | THE JOINT CORP | $9,799,000 | -7.1% | 116,763 | -46.5% | 0.59% | -15.9% |
| QDEL | Sell | QUIDEL CORP | $9,279,000 | -34.2% | 72,424 | -34.3% | 0.56% | -40.4% |
| NVTA | Buy | INVITAE CORPORATION | $8,612,000 | -10.7% | 255,316 | +1.1% | 0.52% | -19.2% |
| MRVI | Sell | MARAVAI LIFE SCIENCES | $8,435,000 | -51.8% | 202,138 | -58.8% | 0.51% | -56.4% |
| MIRO | New | MIROMATRIX MEDICAL INC | $5,534,000 | – | 475,000 | +100.0% | 0.33% | – |
| ANNX | New | ANNEXON BIOSCIENCES INC | $4,639,000 | – | 206,077 | +100.0% | 0.28% | – |
| SLP | Buy | SIMULATIONS PLUS INC | $4,164,000 | -11.1% | 75,832 | +2.4% | 0.25% | -19.6% |
| LHCG | Sell | LHC GROUP INC | $3,088,000 | +4.2% | 15,422 | -0.5% | 0.18% | -6.1% |
| SIEN | Buy | SIENTRA INC | $2,590,000 | +18.4% | 325,352 | +8.5% | 0.16% | +6.9% |
| FATE | New | FATE THERAPEUTICS INC | $1,337,000 | – | 15,400 | +100.0% | 0.08% | – |
| ITGR | INTEGER HOLDINGS CORPORATION | $551,000 | +2.4% | 5,846 | 0.0% | 0.03% | -8.3% | |
| WAT | WATERS CORPORATION | $531,000 | +21.8% | 1,536 | 0.0% | 0.03% | +10.3% | |
| NUVA | NUVASIVE INC | $532,000 | +3.3% | 7,850 | 0.0% | 0.03% | -5.9% | |
| AVTR | AVANTOR INC | $518,000 | +22.7% | 14,596 | 0.0% | 0.03% | +10.7% | |
| NVST | ENVISTA HOLDINGS CORP | $510,000 | +6.0% | 11,793 | 0.0% | 0.03% | -3.1% | |
| SYNH | SYNEOS HEALTH INC CLASS A | $513,000 | +17.9% | 5,736 | 0.0% | 0.03% | +6.9% | |
| HRC | HILL ROM HOLDINGS | $494,000 | +2.9% | 4,346 | 0.0% | 0.03% | -6.2% | |
| GSK | GLAXOSMITHKLINE PLC | $501,000 | +11.6% | 12,574 | 0.0% | 0.03% | 0.0% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $485,000 | +5.9% | 7,256 | 0.0% | 0.03% | -3.3% | |
| BAX | BAXTER INTERNATIONAL INC | $477,000 | -4.6% | 5,929 | 0.0% | 0.03% | -12.1% | |
| ANTM | ANTHEM INC COM | $475,000 | +6.3% | 1,244 | 0.0% | 0.03% | -6.7% | |
| GILD | GILEAD SCIENCES INC | $462,000 | +6.7% | 6,705 | 0.0% | 0.03% | -3.4% | |
| CVS | CVS HEALTH CORPORATION | $461,000 | +11.1% | 5,519 | 0.0% | 0.03% | 0.0% | |
| BDX | Buy | BECTON DICKINSON AND CO | $459,000 | +13.6% | 1,888 | +13.6% | 0.03% | +3.7% |
| CI | CIGNA CORPORATION | $461,000 | -1.9% | 1,943 | 0.0% | 0.03% | -9.7% | |
| HUM | New | HUMANA INC | $473,000 | – | 1,068 | +100.0% | 0.03% | – |
| PRGO | PERRIGO COMPANY | $450,000 | +13.1% | 9,823 | 0.0% | 0.03% | +3.8% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $442,000 | +7.3% | 2,466 | 0.0% | 0.03% | 0.0% | |
| TAK | New | TAKEDA PHARMACEUTICAL CO | $431,000 | – | 25,630 | +100.0% | 0.03% | – |
| ICUI | ICU MEDICAL INC | $420,000 | +0.2% | 2,039 | 0.0% | 0.02% | -10.7% | |
| ABBV | Sell | ABBVIE | $421,000 | -34.9% | 3,740 | -37.5% | 0.02% | -41.9% |
| HOLX | HOLOGIC INC | $390,000 | -10.3% | 5,845 | 0.0% | 0.02% | -20.7% | |
| SNY | SANOFI-SYNTHELABO | $350,000 | +6.4% | 6,650 | 0.0% | 0.02% | -4.5% | |
| JNJ | JOHNSON & JOHNSON | $356,000 | +0.3% | 2,161 | 0.0% | 0.02% | -12.5% | |
| PFE | PFIZER INC | $332,000 | +8.1% | 8,469 | 0.0% | 0.02% | 0.0% | |
| UHS | UNIVERSAL HEALTH SERVICES, INC CLASS B | $300,000 | +9.9% | 2,050 | 0.0% | 0.02% | 0.0% | |
| EBS | EMERGENT BIOSOLUTIONS INC | $270,000 | -32.3% | 4,294 | 0.0% | 0.02% | -38.5% | |
| MCK | MCKESSON CORP | $257,000 | -2.3% | 1,346 | 0.0% | 0.02% | -11.8% | |
| MASS | Exit | 908 DEVICES INC | $0 | – | -20,700 | -100.0% | -0.07% | – |
| QTRX | Exit | QUANTERIX CORPORATION | $0 | – | -27,100 | -100.0% | -0.10% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -117,848 | -100.0% | -0.25% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -53,484 | -100.0% | -0.58% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -358,439 | -100.0% | -1.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.